Bumper Offer - Urjas oil Just @ Rs. 1
Laveta M Syrup, a prescription drug, is manufactured in various forms such as Syrup. Other than this, Laveta M Syrup has some other therapeutic uses, which have been discussed ahead.
The right dosage of Laveta M Syrup depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
The most common side effects of Laveta M Syrup are Headache, Stomach ache, Joint pain. Normally, these side effects of Laveta M Syrup are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
Laveta M Syrup's effect during pregnancy is Severe and Severe while nursing. In addition, Laveta M Syrup's effects on the liver, heart and kidney are discussed below in the Laveta M Syrup related warnings section.
Laveta M Syrup is not recommended if you suffer from certain medical conditions as it can have adverse effects. Liver Disease are examples of such conditions.
Drug interactions for Laveta M Syrup have been reported in the medical literature. Refer to the list below for further details.
In addition to the above precautions for Laveta M Syrup, it is important to know that it is not safe while driving, and is not habit-forming.
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Laveta M Syrup safe for pregnant women?
Laveta M should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Laveta M Syrup safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Laveta M. So it is adviced to consult the doctor before using it.
What is the effect of Laveta M Syrup on the Kidneys?
In the absence of any scientific study on the side effects of Laveta M on kidney, information on safety of Laveta M for kidney is unavailable.
What is the effect of Laveta M Syrup on the Liver?
There is no research available on the side effects of Laveta M on the liver. Therefore, its impact is unknown.
What is the effect of Laveta M Syrup on the Heart?
No research work has been carried out till date on effects of Laveta M on heart. So it is not known whether taking Laveta M will cause side effects on heart or not.
Laveta M Syrup should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Laveta M Syrup unless your doctor advises you to do so -
Is this Laveta M Syrup habit forming or addictive?
Forming a habit of Laveta M Syrup has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Laveta M Syrup. So it is best to avoid driving.
Is it safe?
Yes, but consume Laveta M Syrup only on doctor's advice.
Is it able to treat mental disorders?
Laveta M Syrup is unable to treat or cure mental disorders.
Interaction between Food and Laveta M Syrup
Due to the absence of research, it is difficult to say how Laveta M Syrup and food will interact.
Interaction between Alcohol and Laveta M Syrup
Information about the interaction of Laveta M Syrup and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xyzal® (levocetirizine dihydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 164,167
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 873-874
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 228
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Singulair® (montelukast sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lukair® (montelukast sodium)
Product Index [Internet]: MONTAIR LC & MONTAIR LC KID DT / Syrup (Montelukast sodium + Levocetirizine dihydrochloride ). Ciplamed
Highlights of Prescribing Information [Internet]: XYZAL® (levocetirizine dihydrochloride) tablets . Initial U.S. Approval: 19952007
Smpc [Internet]: montelukast sodium. Aurobindo Pharma
Package leaflet Information for the patient [Internet]: Xyzal 0.5 mg/ml oral solution. UCB Pharma Ltd
